Citigroup Maintains Buy on IDEAYA Biosciences, Raises Price Target to $60

Moomoo 24/7 ·  Mar 21 12:17

Citigroup analyst Yigal Nochomovitz maintains IDEAYA Biosciences (NASDAQ:IDYA) with a Buy and raises the price target from $40 to $60.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment